Sandip Wagh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sandip Wagh has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Manohar V. Padul
Dr. Babasaheb Ambedkar Marathwada University
2 shared publications - Ayesha Shaikh
Department of Biochemistry Dr Babasaheb Ambedkar Marathwada University Aurangabad India
1 shared publication - Faiyaz Khudaboddin Shaikh
Dr. Babasaheb Ambedkar Marathwada University
1 shared publication Harshada Shah
Department of Microbiology, Vedantaa Institute of Medical Sciences and Research Centre, Dhundalwadi, Dahanu, Palghar, Maharashtra, India
1 shared publication- Harshada Shah
Faculty of Microbiology, Vedantaa Institute of Medical Sciences and Research Center, Dahanu-401606, Maharashtra, India
1 shared publication Kalpesh Khutade
Department of Biological Sciences, Sandip University, Nashik, India
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Advanced Research Publications in Journal of Communicable Diseases
- Vol. 58 (03) , 33-42
Demographic Characteristics and Clinical– Radiological Profiles in Molecular Detection of Pulmonary Tuberculosis
Aim: This study evaluated PTB demographics, clinical/radiographic features, and the diagnostic accuracy of chip-based PCR techniques in suspects. Methods: This cross-sectional WHO-aligned PTB study collected patient data, standardized chest X-rays, and evaluated sputum micro real-time PCR to their reference standard Middlebrook 7H9 culture. Results: PTB burden was highest in men aged 51 to 60 with moderate to- high incomes, with heavy smoking as the main risk factor. Higher bacterial loads correlated with worse clinical severity, and reticulonodular opacities were the most common radiological finding (41.1%; p less than 0.0001). Bacterial (40.1%) and fungal (36.7%) co-infections were more frequent than diabetes or HIV (p less than 0.001). TrueNat showed the highest diagnostic accuracy (98.2%), whereas chest radiography was significantly less accurate. Conclusion: PTB risk was driven by demographics and behavior, while TrueNat far outperformed radiology in diagnostic accuracy. DOI: https://doi.org/10.24321/0019.5138.202653 How to cite this article:Khutade K, Wagh S, Shah H, Kumar R. Demo graphic Characteristics and Clinical–Radiological Profiles in Molecular Detection of Pulmonary Tuberculosis. J Commun Dis. 2026;58(3):33-42.
- 30 September 2026
- Published by Advanced Research Publications in Journal of Communicable Diseases
- Vol. 58 (03) , 33-42
Open AccessDemographic Characteristics and Clinical– Radiological Profiles in Molecular Detection of Pulmonary Tuberculosis
Aim: This study evaluated PTB demographics, clinical/radiographic features, and the diagnostic accuracy of chip-based PCR techniques in suspects. Methods: This cross-sectional WHO-aligned PTB study collected patient data, standardized chest X-rays, and evaluated sputum micro real-time PCR to their reference standard Middlebrook 7H9 culture. Results: PTB burden was highest in men aged 51 to 60 with moderate to- high incomes, with heavy smoking as the main risk factor. Higher bacterial loads correlated with worse clinical severity, and reticulonodular opacities were the most common radiological finding (41.1%; p less than 0.0001). Bacterial (40.1%) and fungal (36.7%) co-infections were more frequent than diabetes or HIV (p less than 0.001). TrueNat showed the highest diagnostic accuracy (98.2%), whereas chest radiography was significantly less accurate. Conclusion: PTB risk was driven by demographics and behavior, while TrueNat far outperformed radiology in diagnostic accuracy. DOI: https://doi.org/10.24321/0019.5138.202653 How to cite this article:Khutade K, Wagh S, Shah H, Kumar R. Demo graphic Characteristics and Clinical–Radiological Profiles in Molecular Detection of Pulmonary Tuberculosis. J Commun Dis. 2026;58(3):33-42.
- Open Access
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Microbiology Research
- Vol. 11 (3) , 147-155
An array of various microbiological diagnostic modalities for pulmonary tuberculosis: A review
Pulmonary tuberculosis (TB) is a public health concern in India and rapid diagnostic and cutting-edge methods are needed to identify its drug-resistant forms. The National Strategic Plan 2017-2025 aims for a "TB-Free India" by 2025, based on the 'Detect, Treat, Prevent, and Build' pillars. The aim of this review was to present an updated overview of current initiatives to improve traditional diagnostic techniques as well as novel molecular methods for diagnosis of pulmonary tuberculosis patients.The studies were scanned for published publications on tuberculosis, Mycobacterium, TB culture, and other methodologies using a range of scientific sources, including PubMed and Google Scholar. Although a plethora of diagnostic tests are available for pulmonary tuberculosis, each has limitations and advantages. Nonetheless, a combination of tests allows us to obtain an accurate diagnosis more quickly, which helps us to treat these individuals effectively. Rapid reporting and treatment decisions are necessary for tuberculosis diagnosis; however, there are issues with the current approaches- Certain individuals may receive false positive findings, including those who have received prior BCG vaccinations, young people infected with Mycobacterium tuberculosis (MTB), and people coinfected with HIV. The World Health Organization (WHO) recommends next-generation Nucleic Acid Amplification Tests (NAATs) for point-of-care diagnostic healthcare settings, such as GeneXpert MTB/RIF (GX), and proposes POC-NAATs (2nd generation) for TB detection in the future.
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Microbiology Research
- Vol. 11 (3) , 147-155
Open AccessAn array of various microbiological diagnostic modalities for pulmonary tuberculosis: A review
Pulmonary tuberculosis (TB) is a public health concern in India and rapid diagnostic and cutting-edge methods are needed to identify its drug-resistant forms. The National Strategic Plan 2017-2025 aims for a "TB-Free India" by 2025, based on the 'Detect, Treat, Prevent, and Build' pillars. The aim of this review was to present an updated overview of current initiatives to improve traditional diagnostic techniques as well as novel molecular methods for diagnosis of pulmonary tuberculosis patients.The studies were scanned for published publications on tuberculosis, Mycobacterium, TB culture, and other methodologies using a range of scientific sources, including PubMed and Google Scholar. Although a plethora of diagnostic tests are available for pulmonary tuberculosis, each has limitations and advantages. Nonetheless, a combination of tests allows us to obtain an accurate diagnosis more quickly, which helps us to treat these individuals effectively. Rapid reporting and treatment decisions are necessary for tuberculosis diagnosis; however, there are issues with the current approaches- Certain individuals may receive false positive findings, including those who have received prior BCG vaccinations, young people infected with Mycobacterium tuberculosis (MTB), and people coinfected with HIV. The World Health Organization (WHO) recommends next-generation Nucleic Acid Amplification Tests (NAATs) for point-of-care diagnostic healthcare settings, such as GeneXpert MTB/RIF (GX), and proposes POC-NAATs (2nd generation) for TB detection in the future.
- 13 August 2020
- Published by Wiley in Biomedical Chromatography
- Vol. 34 (12) , e4966
Metabolite profiling of arginase inhibitor activity guided fraction of Ficus religiosa leaves by LC–HRMS
Cardiovascular disease is one of the major causes of deaths worldwide. Increased arginase activity is associated with cardiovascular disease. The literature shows that plants are a good source of arginase inhibitors. Hence in the present work arginase inhibitor activity is studied from Ficus religiosa leaves. A fine powder of F. religiosa leaves was serially extracted in various solvents, viz. hexane, chloroform, ethyl acetate and methanol. Out of those four solvent extracts, the one showing highest arginase inhibitor activity was loaded onto the column for further fractionation. Among the collected fractions, the one showing the highest activity was subjected to identification of metabolites by using LC–HRMS. Total compounds including acipimox, edoxudine, levulinic acid, hydroxyhydroquinone, ramiprilglucuronide, berberine, antimycin A, swietenine and some short peptides were identified from the fraction showing the highest arginase inhibitory activity. Identification of these metabolites from F. religiosa and their biological importance may help to promote its use as medicinal plant. Further purification and characterization of therapeutically novel molecules will be the subject of future work.
- 13 August 2020
- Published by Wiley in Biomedical Chromatography
- Vol. 34 (12) , e4966
Metabolite profiling of arginase inhibitor activity guided fraction of Ficus religiosa leaves by LC–HRMS
Cardiovascular disease is one of the major causes of deaths worldwide. Increased arginase activity is associated with cardiovascular disease. The literature shows that plants are a good source of arginase inhibitors. Hence in the present work arginase inhibitor activity is studied from Ficus religiosa leaves. A fine powder of F. religiosa leaves was serially extracted in various solvents, viz. hexane, chloroform, ethyl acetate and methanol. Out of those four solvent extracts, the one showing highest arginase inhibitor activity was loaded onto the column for further fractionation. Among the collected fractions, the one showing the highest activity was subjected to identification of metabolites by using LC–HRMS. Total compounds including acipimox, edoxudine, levulinic acid, hydroxyhydroquinone, ramiprilglucuronide, berberine, antimycin A, swietenine and some short peptides were identified from the fraction showing the highest arginase inhibitory activity. Identification of these metabolites from F. religiosa and their biological importance may help to promote its use as medicinal plant. Further purification and characterization of therapeutically novel molecules will be the subject of future work.